Laboratory Procedure for Immunoglobulin Gene Analysis


Contact and Shipping Details


If your country doesn't belong to the European Union, it is compulsory to provide the VAT/TAX number of your laboratory (HST, Federal Tax Number, ID...)  

Patient Material
On completing the form, please tick the box that most accurately reflects your routine laboratory practice. 

Requested material for accreditation

Shipment

If shipment by transportation paid by the participant, please provide name of company

Source of cells

Anticoagulant

Work-up of cells

Nucleic Acid

DNA Extraction Method

Please provide a brief description below

RNA Extraction / cDNA Synthesis Methods

Please provide a brief description below



PCR Methodology

General Strategy

5´ Primer Used

3´ Primer Used

Reference for Primer Sets Used

Quantity of DNA / cDNA Used

Taq Polymerase Used (Including Company Name)



Evaluation / Processing of PCR Products

Analysis of PCR Products Prior to Sequencing

If yes, by

Purification of PCR Product Prior to Sequencing

Cloning of PCR Product Prior to Sequencing

If yes, please provide the situations and estimated frequency for when cloning is applied

Cloning Kit Used (including Company Name)

Prior to sequencing, do you check the clones for the correct insert?

Number of clones selected for Sequencing



Sequencing

General Strategy

Primers Used for Sequencing

Strands Sequenced

Bioinformatics Tools for Sequence Analysis - Please specify tools/programs used for: Visualisation of Chromatograms

Please specify tools/programs used for: Alignment of Both Strands (Forward and Reverse)

Please specify tools/programs used for: Multiple Sequence Alignment e.g. after Cloning

Please comment on any additional bioinformatic databases utilised

Bioinformatics Tools for Sequence Interpretation - Please specify the Tools/Programs utilised for each of the following: Identification of IGHV, IGHD, IGHJ Gene and Allele

Calculation of the Percentage Identity to the Germline

Do you exclude from the calculation the sequence corresponding to the 5´ primer?

Do you include in the calculation mutations within the HCDR3 of the IG gene?

Interpretation of Difficult Cases: Briefly outline how each of the following situations are handled/interpreted: Single Unproductive Rearrangements

Double Productive Rearrangements



Reporting IG Sequence Data in Clinical Routine Reporting IG Sequence Data in Clinical Routine

Briefly outline the information you currently provide in a Laboratory Report for IGHV Gene Mutation Status, e.g. tissue type, gDNA/cDNA, PCR primers, gene usage, % identity, functionality, conclusion, etc.

Briefly outline how you would report each of the following cases: 1. Mutated ´Borderline´ Rearrangement

2. Single Unproductive IGHV Rearrangement

3. Double Productive IGHV Rearrangements

4. Double Productive Rearrangements with Discordant Mutational Status

5. IGHV3-21 Rearrangement


 

Your form has been successfully submitted!


You will receive a confirmation email with more information of the process.


Go back to the web
We are using a temporary cookie to streamline your experience. No personal data is stored and the cookie is removed once you complete your registration.

Your Browser Settings have Cookies Disabled

This site requires a temporary cookie to streamline your experience. No personal data is stored and the cookie will be removed once you complete your registration. Please enable cookies in your browser and refresh this page.